← All organizations
Highest phase reached
Phase 1
First clinical trial
Aug 1, 2017Last known activity
Oct 24, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 2 trials)
Phase 1 (4 own, 0 via acquisition)
Indications
Studied for
- Acute Disease
- Blast Crisis
- Leukemia
- Leukemia, Biphenotypic, Acute
- Leukemia, Lymphoid
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Leukemia, Myelomonocytic, Acute
- Leukemia, Myelomonocytic, Chronic
- Leukemia, Myelomonocytic, Juvenile
- Myelodysplastic Syndromes
- Neoplasms
- Neuroblastoma
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Preleukemia
- Syndrome
Recent trials (2)
- NCT06156410CollaboratorPhase 1Oct 24, 2023
- NCT02439788CollaboratorPhase 1Aug 1, 2017
Details
- Last known activity
- Oct 24, 2023